Correlation between HIV-specific CD8 cell production of interferon-γ and plasma levels of HIV RNA in perinatally infected pediatric populations

Journal of Infectious Diseases

Volumn 190, Issue 4, 2004, Pages 722-726

  Borkowsky, William ^a   Zhan, Ming Xia ^a   Chen, Song He ^a   Ilmet, Tiina ^a   Kaul, Aditya ^a   Chandwani, Sulachni ^a   Rigaud, Mona ^a   Essajee, Shaffiq ^a   Gruber, Caroline ^a   Freedman, Abigail ^a   Krasinski, Keith ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; NEF PROTEIN; POL PROTEIN; VIRUS RNA; VIRUS VECTOR;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PERINATAL INFECTION; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; MALE; RNA, VIRAL; SPECIES SPECIFICITY; VIRAL LOAD;

EID: 3943059420     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422757     Document Type: Article

References (16)

1. Larsson M, Jin X, Ramratnam B, et al. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 1999; 13:767-77.
2. Spiegel HM, DeFalcon E, Ogg GS, et al. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children. J Infect Dis 1999; 180:359-68.
3. + T cells in infected children correlate positively with plasma viral load. J Virol 2002; 76:12414-22.
4. Lubaki NM, Shepherd ME, Brookmeyer RS, et al. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement. J Acquir Immune Defic Syndr 1999; 22:19-30.
5. Brander C, Goulder PJ, Luzuriaga K, et al. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection. J Immunol 1999; 162:4796-800.
6. Goulder PJ, Brander C, Annamalai K, et al. Differential narrow focusing of immunodominant human immunodeficiency virus Gag-specific cytotoxic T-lymphocyte responses in infected African and Caucasoid adults and children. J Virol 2000; 74:5679-90.
7. Larsson M, Jin X, Ramratnam B, et al. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 1999; 13:767-77.
8. Samri A, Haas G, Duntze J, et al. Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. J Virol 2000; 74:9306-12.
9. Schmitt M, Harrer E, Goldwich A, et al. Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes. AIDS 2000; 14:653-8.
10. Harrer E, Harrer T, Barbosa P, et al. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J Infect Dis 1996; 173:476-9.
11. Luzuriaga K, McManus M, Catalina M, et al. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol 2000; 74:6984-91.
12. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169-80.
13. Spiegel HM, Chandwani R, Sheehy ME, et al. The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children. J Infect Dis 2000; 182:88-95.
14. McFarland E, Borkowsky W, Muresan P, et al. Increases in HIV-specific interferon-γ and proliferative responses in children undergoing structured treatment interruption (STI) [abstract 917]. In: Programs and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2004.
15. Adkins B, Bu Y, Guevara P. The generation of Th memory in neonates versus adults: prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates. J Immunol 2001; 166:918-25.
16. Sarzotti M, Robbins D, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996; 271:1726-8.